Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Mar;16(2):240-5.
doi: 10.4103/2230-8210.93742.

LIPITENSION: Interplay between dyslipidemia and hypertension

Jamshed J Dalal  1 , T N C Padmanabhan, Piyush Jain, Shiva Patil, Hardik Vasnawala, Ashish Gulati
Affiliations

LIPITENSION: Interplay between dyslipidemia and hypertension

Jamshed J Dalal et al. Indian J Endocrinol Metab. 2012 Mar.

Abstract

The burden of cardiovascular disease (CVD) is increasing worldwide. The increase in the burden is a major concern in developing countries like India. It is well-established that hypertension and dyslipidemia are the two major contributing risk factors for CVD. Various epidemiological studies have shown the prevalence of the co-existence of hypertension and dyslipidemia, in the range of 15 to 31%. The co-existence of the two risk factors has more than an additive adverse impact on the vascular endothelium, which results in enhanced atherosclerosis, leading to CVD. This review emphasizes on the 'co-existence and interplay of dyslipidemia and hypertension'. The authors have termed the co-existence as, 'LIPITENSION'. The term LIPITENSION may help clinicians in easy identification and aggressive management of the two conditions together, ultimately preventing future cardiovascular events.

Keywords: Cardiovascular risk factors; dyslipidemia; hypertension; lipitension.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

References

    1. Bethesda: National Heart, Lung, and Blood Institute; 2001. May, Third Report of the National Cholesterol Education Program (NCEP) Expert Panel. Detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III) NIH Publication No. 01-3670.
    1. Williams RR, Hunt SC, Hopkins PN, Stults BM, Wu LL, Hasstedt SJ, et al. Familial dyslipidemic hypertension: Evidence from 58 Utah families for a syndrome present in approximately 12% of patients with essential hypertension. JAMA. 1988;259:3579–86. - PubMed
    1. Williams RR, Hopkins PN, Hunt SC, Wu LL, Hasstedt SJ, Lalouel JM, et al. Population-based frequency of dyslipidemia syndromes in coronary-prone families in Utah. Arch Intern Med. 1990;150:582–8. - PubMed
    1. Steinberg O. Insulin resistance and hypertension. In: Izzo JL Jr, Black HR, editors. Hypertension Primer. The Essentials of High Blood Pressure. 2nd ed. American Heart Association, Dallas TX: Lippincott, Williams and Williams; 1999. pp. 121–2.
    1. Kannel WB. Fifty years of Framingham study contributions to understanding hypertension. J Hum Hypertens. 2000;14:83–90. - PubMed